12/10/2018 16:45:32

RAMSAY GENERALE DE SANTE : supplement to the offer document in respect of the public offer to the shareholders of Capio

PRESS RELEASE

THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO

AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRIC

A. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCES WILL NOT BE APPROVED FROM) PERSONS IN THOSE JURISDICTIONS OR ANY OTHER JURISDICTION WHERE SUCH PERSONS' ACCEPTANCE OF THE OFFER REQUIRES FURTHER OFFER DOCUMENTS, FILINGS OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED UNDER SWEDISH LAW.

Ramsay Générale de Santé publishes a supplement to the offer document in respect of the public offer to the shareholders of Capio

Paris, 12 October 2018 - Ramsay Générale de Santé S.A. ("RGdS") has today published a supplement to the offer document in respect of the public offer (the "Offer") to the shareholders of Capio AB (publ) ("Capio") that was approved and registered by the Swedish Financial Supervisory Authority (the "SFSA") on 5 September 2018 and published by RGdS the same day (the "Offer Document").

The supplement to the Offer Document (the "Supplement") has been prepared due to the publication of (i) RGdS' press release on 8 October 2018 regarding the increase of the Offer consideration to SEK 58 and the waiver of the competition clearance condition, (ii) RGdS' press release on 10 October 2018 regarding the lowering of the minimum acceptance condition to 75 per cent, (iii) Capio's press release on 10 October 2018 regarding, inter alia, its board of directors' unanimous decision to recommend the shareholders to accept the Offer and (iv) Capio's press release on 11 October 2018 regarding preliminary quarterly results for the period July-September 2018.

The Supplement was approved and registered by the SFSA today on 12 October 2018 and is now available on RGdS' website (www.ramsaygds.se) and Handelsbanken's website (www.handelsbanken.se/

investeringserbjudande). The Supplement forms part of the Offer Document and must be read together with the Offer Document.

Further information

This press release was submitted for publication on 12 October 2018 at 5:45 p.m. CET.

For more information about the Offer, please visit www.ramsaygds.se.

For further information about RGdS, please contact:

Caroline DESAEGHER | Press contact

C.DESAEGHER@ramsaygds.fr

Arnaud JEUDY | Investor relations

A.JEUDY@ramsaygds.fr

or visit www.ramsaygds.fr.

Important information

The Offer is not being made to, and acceptances will not be approved from, persons whose participation in the Offer requires that an additional offer document is prepared or registration effected or that any other measures are taken in addition to those required under Swedish law (including Nasdaq Stockholm's Takeover Rules), except where there is an applicable exemption.

This press release, the Offer Document, the Supplement, the acceptance form and any documentation related to the Offer (including copies thereof) must not be mailed or otherwise distributed, forwarded or sent in or into any jurisdiction (including without limitation Australia, Canada, Hong Kong, Japan, New Zealand or South Africa) in which the distribution of such documentation or the Offer would require any additional measures to be taken or would be in conflict with any law or regulation in any such jurisdiction. Persons who receive this press release, the Offer Document, the Supplement, or the acceptance form (including without limitation banks, brokers, dealers, nominees, trustees and custodians) and are subject to the laws or regulations of any such jurisdiction will need to inform themselves about, and observe, any applicable restrictions or requirements. Any failure to do so may constitute a violation of the securities laws or regulations of any such jurisdiction. To the extent permitted by applicable law, RGdS disclaims any responsibility or liability for any violations of any such restrictions by any person and RGdS reserves the right to disregard any purported acceptance of the Offer resulting directly or indirectly from a violation of any of these restrictions.

Statements in this press release relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as "anticipate", "believe", "expect", "intend", "plan", "seek", "will", "would" or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that could occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside RGdS' control. Any such forward-looking statements speak only as of the date on which they are made and RGdS has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise.

This press release has been published in English, French and Swedish. In the event of any discrepancy between the three language versions, the English version shall prevail.

Information for U.S. securityholders

The Offer described in this press release, the Offer Document and the Supplement is made for the securities of Capio and is subject to the laws of Sweden. It is important that U.S. holders understand that the Offer, this press release and the Offer Document are subject to disclosure and takeover laws and regulations in Sweden that may be different from those in the United States. To the extent applicable, RGdS will comply with Regulation 14E under the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act").

RGdS intends to treat the Offer as one to which the "Tier II" exemption mentioned in Rule 14d-1(d) under the Exchange Act applies. Pursuant to an exemption from Rule 14e-5 under the Exchange Act, RGdS may, from time to time, purchase or make arrangements to purchase shares outside the Offer from the time the Offer was announced until the expiration of the acceptance period of the Offer, including purchases in the open market at prevailing prices or in private transactions at negotiated prices and to the extent permitted under the applicable Swedish laws and regulations and provided certain other conditions are met. Any change in RGdS' shareholding in Capio which entails that RGdS' holding of shares or votes in Capio reaches, exceeds or falls below any of the limits of 5, 10, 15, 20, 25, 30, 50, 662/3 or 90 per cent will be reported in writing by RGdS to Capio and the SFSA in accordance with Chapter 4 of the Swedish Financial Instruments Trading Act. The SFSA will publish the information not later than noon on the trading day following the day on which the SFSA received the report. Such information regarding purchases of shares in Capio outside of the Offer will also be disclosed in the United States.

Neither the U.S. Securities and Exchange Commission nor any securities commission of any state of the United States has (a) approved or disapproved the Offer, (b) passed upon the merits or fairness of the Offer, or (c) passed upon the adequacy or accuracy of the disclosure in this press release, the Offer Document or the Supplement. Any representation to the contrary is a criminal offence in the United States.

About Ramsay Générale de Santé

Ramsay Générale de Santé S.A. is listed on the regulated market of Euronext in Paris and is included in the Mid Cap index. Ramsay Générale de Santé is a leading group in the private healthcare sector in France with 23,000 employees in 120 private clinics. The group works with 6,000 practitioners, forming a leading independent medical community in France. A major player in hospitalisation, Ramsay Générale de Santé provides a comprehensive range of patient care services in three business segments: Medicine-Surgery-Obstetrics, sub-acute care and rehabilitation, and mental health. Ramsay Générale de Santé has developed a unique healthcare service, built around the quality and security of patient care and organisational efficiency. The group takes a comprehensive approach to patient care, including personalised assistance and support before, during and after hospitalisation. Ramsay Générale de Santé also participates in public service missions in its sector and helps to strengthen France's mainland healthcare network.

Site Internet: www.ramsaygds.fr

Facebook: https://www.facebook.com/RamsayGDS

Twitter: https://twitter.com/RamsayGDS

LinkedIn: https://www.linkedin.com/company/ramsaygds

YouTube: https://www.youtube.com/channel/UCpSNsGhH-xc84K6Fv7XxKPw

Press Contact

Ramsay Générale de Santé : Caroline Desaegher - Communication Director - c.desaegher@ramsaygds.fr

RGDS : supplement OPA CAPIO


This announcement is distributed by West Corporation on behalf of West Corporation clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: RAMSAY GENERALE DE SANTE via Globenewswire

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
07 Dec
VELO
Nedenfor vil jeg give et overblik over hvorfor jer er aktionær. Jeg tager måske fejl med mine antage..
38
07 Dec
VELO
CANADA godkendelse (ENDO)   Jeg lovede i en tråd for 2 uger siden at undersøge hvornår vi kan forven..
36
06 Dec
SAS-DKK
SAS aktien har fået kursklø efter et flot og fornemt regnskab, ledelsen vil ikke give budget for reg..
32
08 Dec
VELO
Havde igår en lang snak med min kapitalforvalter emnet - hvordan er det gået Hr og Fru Danmark's por..
27
10 Dec
VELO
Når man følger Veloxis-debatten, og det hr jeg gjort i mange, mange år - også da den hed LCP, så går..
16
06 Dec
VELO
  Man kan ikke være i tvivl om formålet med nyt afsnit, samt formuleringen i overskriften, når man s..
16
10 Dec
I:DAX
Det der foregår har da absolut intet med et flash crash at gøre ! Lad dog være med at brug fine bete..
15
10 Dec
 
Klart, klart... et firma, der reklamerer må være desperat. Personligt synes jeg ikke Pandora har n..
15
05 Dec
DANSKE
Danske bank er ikke mere kriminel end en politibetjent der ikke anholder en butikstyv.
14
06 Dec
 
Dette er hvad jeg kan læse, inden betalingsmuren sænker sig: Berlingske Media skruer op for ambition..
13

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
2
Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea
3
Uptick Newswire’s Stock Day Podcast Hosts Medifocus, Inc.’s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers
4
WISeKey Secures Printer Systems, from Cartridge to Cloud, with WISePrint@Cloud
5
Flame Seal Products FS-PG Wildfire Protection System Proves Totally Effective in Raging California Wildfire

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 03:12:55
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB6 - 2018-12-11 04:12:55 - 2018-12-11 03:12:55 - 1000 - Website: OKAY